Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide.
$0.18-11.60%
报价 2026-11-09
市值
$13.8M
EV
$1.79B
PE (TTM)
–
预期 PE (FY2026)
0.4x
52 周区间距高点 -95.4%
$0.18$3.89
筛选结果
pipeline · 2026-11-09Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| ACHAccendra Health, Inc. | $13.8M | -11.6% | -6.8% | 44.8% | – | 7.8x | – | |
| ACRSAclaris Therapeutics, Inc. | $624.1M | +8.7% | -29.5% | 95.6% | – | – | – | |
| SGHTSight Sciences, Inc. | $606.5M | +9.2% | +18.4% | 88% | – | – | – | |
| EDITEditas Medicine, Inc. | $422.3M | +7.0% | +7.1% | 56.9% | – | – | – | |
| ALLOAllogene Therapeutics, Inc. | $366.2M | +1.9% | -18.1% | 0% | – | – | – | |
| CGCCanopy Growth Corporation | $263.7M | -4.4% | – | 27.4% | – | – | – | |
| CABACabaletta Bio, Inc. | $254.3M | +15.4% | -43.2% | 0% | – | – | – | |
| HITIHigh Tide Inc. | $233.6M | -0.4% | – | 26.5% | – | – | – | |
| BIOABioAge Labs, Inc. | $214.2M | +6.6% | -16.9% | 99.4% | – | – | – | |
| 同行中位数 | – | – | -17.5% | 42.1% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。